Androgen News and Research

RSS

Androgen deprivation therapy linked to increased risk of heart disease death

The use of androgen deprivation therapy to treat localized prostate cancer is associated with an increased risk of death from heart disease, according to a study published online October 9 in the Journal of the National Cancer Institute .

10 Oct 2007

Prostate cancer treatment may encourage spread of cancer cells

According to a new study by researchers in the U.S. the popular prostate cancer treatment, androgen deprivation therapy, may in fact encourage the spread of cancer cells throughout the body.

3 Oct 2007

Additional biopsy-scoring data may help determine prostate cancer prognosis

Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the October 3 issue of JAMA.

3 Oct 2007

Androgen deprivation therapy for prostate cancer may encourage spread of disease

A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests.

1 Oct 2007

Male contraception

For decades, pundits have predicted new contraceptives for men within the next 5 to 10 years.

29 Sep 2007

Exercise might actually increase the risk of developing ovarian cancer

Barcelona, Spain: A new study adds fuel to the debate over whether being fat or inactive affects the risk of developing ovarian cancer.

27 Sep 2007

Diet and medications may assist prevention of prostate cancer

Recent investigations of medications, diet and the molecular understanding of prostate cancer are defining potential prevention strategies for the disease, and herald a new stage in the management of this cancer, according to a new review.

25 Sep 2007

Causes and treatments for gynecomastia

Gynecomastia, the benign enlargement of male breast tissue, is a common occurrence in adolescents as well as in middle-aged and older men.

20 Sep 2007

Lavender oil and tea tree oil may make boy's breasts bigger

A study published in this week's issue of the New England Journal of Medicine suggests that repeated topical use of products containing lavender oil and/or tea tree oil may cause prepubertal gynecomastia, a rare condition resulting in enlarged breast tissue in boys prior to puberty, and for which a cause is seldom identified.

5 Sep 2007

Sex hormones play a significant role in the development of diabetic kidney disease

Women have a "female advantage" when it comes to chronic kidney disease. When compared to men, they have fewer and less severe episodes of this disorder throughout most of their lives.

11 Aug 2007

Statins do not protect against prostate cancer

A large community-based study refutes previous findings that statins , a top-selling drug class, worldwide -- might cut one's risk of developing prostate cancer by reducing production of the male hormones that fuel cancer growth.

11 Aug 2007

Insulin Resistance Syndrome could be key to preventing cardiovascular disease, cancer, diabetes and Alzheimer's

New and important evidence shows that Insulin Resistance Syndrome can lead to elevated risk for cardiovascular disease, breathing and sleep disorders, liver disease, Polycystic Ovarian Syndrome, type 2 diabetes, certain cancers, Alzheimer's Disease and more.

3 Aug 2007

Gene fusion subtypes in prostate carcinoma have clinical implications

Building on an earlier study that used Oncomine to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).

3 Aug 2007

Detection of gene fusions in prostate cancer

Researchers at the University of Michigan Comprehensive Cancer Center have discovered how genes turn on the switch that leads to prostate cancer.

3 Aug 2007

Women more prone to brain damage from alcohol abuse than men

Alcoholism has traditionally been considered a male disease because there are many more alcoholic males than females.

27 Jul 2007

Abiraterone reduces levels of prostate specific antigen

For prostate cancer patients whose tumors have continued to grow despite medical or surgical castration, a new drug candidate that inhibits production of male hormones anywhere in the body is showing promise in early trials.

9 Jul 2007

Treatment for early prostate cancer associated with type of specialist seen

A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive.

5 Jun 2007

Findings from study of immunotherapy vaccine in prostate cancer patients

Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease will be presented by Oregon Health & Science University Cancer Institute researchers.

5 Jun 2007

Gabapentin reduces hot flashes in men receiving androgen deprivation therapy

North Central Cancer Treatment Group ( http://ncctg/ ) researchers based at Mayo Clinic ( http://www.mayo.edu/ ) in Rochester, Minn., have discovered that low doses of a drug used to prevent epileptic seizures and to treat nerve pain caused by shingles substantially reduces hot flashes in patients who are undergoing anti-hormonal treatment, or androgen-deprivation therapy, for prostate cancer.

5 Jun 2007

Researchers to discuss gene that may be linked to polycystic ovary syndrome

Researchers in endocrinology and obstetrics and gynecology at Cedars-Sinai Medical Center will make several presentations at the upcoming annual meetings of two medical organizations , the Androgen Excess Society (June 1, 2007) and the Endocrine Society (June 2-5, 2007).

3 Jun 2007